<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> survivors are at risk of dying from other causes including comorbidities and <z:e sem="disease" ids="C0085183" disease_type="Neoplastic Process" abbrv="">second malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>This study was undertaken to identify demographic and clinical predictors of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific and competing causes of mortality </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: The crude probabilities of mortality attributed to <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, and non-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> causes were estimated for 19,415 residents of Queensland, Australia, who were diagnosed with a first primary <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> between 1996 and 2007 when aged 20-79 years and survived at least 2 months, with follow-up to the end of 2009 </plain></SENT>
<SENT sid="3" pm="."><plain>Multivariate competing risk analysis was used to analyze covariate effects on the cumulative probability of the different mortality types </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Five-year cumulative probabilities of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, and non-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> mortality were 29.4 % (95 % CI 29.3, 30.7), 2.0 % (95 % CI 1.8, 2.2), and 5.7 % (95 % CI 5.3, 6.0), respectively </plain></SENT>
<SENT sid="5" pm="."><plain>Factors associated with an increased risk of non-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> mortality included older age, male gender, unmarried status, <z:e sem="disease" ids="C0277565" disease_type="Disease or Syndrome" abbrv="">localized disease</z:e>, first primary <z:hpo ids='HP_0003003'>colon cancers</z:hpo>, no surgery, and the presence of comorbidities </plain></SENT>
<SENT sid="6" pm="."><plain>Apart from diagnosis of a metachronous <z:e sem="disease" ids="C0751623" disease_type="Neoplastic Process" abbrv="">secondary cancer</z:e>, being older, unmarried, or in blue-collar occupations were independent predictors of increased mortality due to other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: A better understanding of the role of competing events and the ability to predict risk of such events have the potential to translate into more effective individualized strategies for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> management </plain></SENT>
<SENT sid="8" pm="."><plain>The control of comorbidities and reducing <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk through clinical management and lifestyle changes should be an important and attainable goal for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> survivors </plain></SENT>
</text></document>